IRLA
Quince Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$33.64
+5.03%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$1.39
- Revenue estimate
- —
Latest reported
- Last report date
- —
- EPS actual
- —
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026